Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
CEO and two top executives sold shares worth over $3.8 million in January 2026, according to SEC filings.
On January 13, 2026, Scholar Rock (NASDAQ:SRRK) CEO David Hallal, COO Keith Woods, and CFO Vikas Sinha each sold shares of the company’s stock at an average price of $42.70, totaling approximately $2.45 million, $715,054, and $715,439 respectively.
The transactions reduced their ownership stakes by 3.59%, 2.79%, and 2.79%, respectively.
The sales were disclosed in SEC filings.
Scholar Rock, a clinical-stage biotech firm developing protein therapeutics for diseases involving growth factors, reported a quarterly loss of $0.90 per share, slightly below estimates.
Its lead candidate, SRK-015 (appercept), is under investigation for treating spinal muscular atrophy.
The company has a market cap of $4.75 billion, a negative P/E ratio of -14.77, and analysts maintain a "Buy" consensus with a $50.14 target price.
El CEO y dos altos ejecutivos vendieron acciones por valor de más de $3.8 millones en enero de 2026, según los documentos de la SEC.